Introduction {#s001}
============

In the United States, racial and ethnic disparities in breast cancer surgical care have been demonstrated extensively at the state and nationwide levels.^[@B1]^ Investigators have shown that disparities exist in the receipt of cancer-directed surgery, breast conservation, breast reconstruction, and bilateral mastectomy, even after controlling for the stage of disease.^[@B4]^ Specifically, studies have demonstrated lower utilization of breast conservation, contralateral prophylactic mastectomy, and postmastectomy breast reconstruction by racial and ethnic minorities. While patient-related factors such as income,^[@B10]^ insurance,^[@B10]^ primary language,^[@B11]^ and cultural beliefs^[@B12]^ contribute to differences in receipt of surgical care and surgical decision-making, recent studies have implicated hospital-level factors as significant contributors to persistent disparities.^[@B13],[@B14]^

Racial and ethnic minority patients are more likely to receive care at non-National Cancer Institute (NCI) centers, low-volume hospitals, and lower resource hospitals.^[@B14]^ Furthermore, racial and ethnic minorities more often receive breast cancer treatments at hospitals with predominantly minority populations and Medicaid patients.^[@B18]^ Specifically, Hispanic patients have been shown to have lower utilization of cancer care at NCI-designated cancer centers^[@B19]^ or high-volume hospitals.^[@B20]^

Studies have found that greater distance to a hospital or treatment facility negatively influences the receipt of postlumpectomy breast radiotherapy as well as postmastectomy breast reconstruction.^[@B21]^ On average, white patients travel further to hospitals than black or Hispanic patients in accessing their healthcare needs.^[@B25]^ Furthermore, prior investigations have shown that black and Hispanic patients report that travel distance, access to a car, and availability of a driver limit their potential to access a hospital.^[@B25]^

The Hispanic population of California is heterogeneous and rapidly growing, with an influx of new immigrants from South and Central America. Indeed in 2000, Hispanics composed 32.4% of the state\'s population, which increased to 38.4% by 2013.^[@B26]^ The incidence of breast cancer among Hispanic women is 91.1 per 100,000 population compared with 128.7 for non-Hispanic whites across the United States.^[@B27]^ An estimated 29,360 new cases of breast cancer are expected in California in 2018 and, based on past estimates of the California Cancer Registry, ∼18.4% of these will occur among Hispanic women. However, these ethnic--racial distributions are not necessarily replicated in comprehensive cancer centers.

The aforementioned disparities were the motivating factor to evaluate the delivery of breast cancer surgical care for Hispanic patients at our institution, a tertiary NCI-designated cancer center in California. Moreover, it is possible that the institution\'s outreach in Spanish and efforts to encourage participation in clinical trials would contribute to equitable delivery of care. We hypothesized that Hispanics would not have differences in the receipt of surgical care compared with white patients.

Methods {#s002}
=======

After obtaining Institutional Review Board approval from Stanford University, we obtained deidentified clinical data from the Stanford Cancer Registry Database. Our cohort consisted of female patients who initiated treatment for ductal carcinoma *in situ* (DCIS) or invasive breast cancer at our institution during the years 2010--2014. Our institution is an NCI-designated cancer center. The 10 most represented counties for our cancer center are Santa Clara (30%), San Mateo (14%), Alameda (11%), San Joaquin (4%), Merced (4%), Santa Cruz (4%), Contra Costa (3%), Stanislaus (3%), Monterey (3%), and Solano (1%). The following variables were selected and abstracted: age, ethnicity, insurance status, home zip code, tumor size, and nodal status. Age was categorized as \<45, 45--54, 55--64, 65--74, 75--84, or 85+ years. Patient ethnicity was categorized as Hispanic or non-Hispanic. Patients with unknown ethnicity were excluded from the analysis. All patients included for study had complete demographic and clinical data, and thus the sample size was equal for all analyses. Distance traveled was calculated using Google Maps and measured from a central point of the recorded patient zip code to the address of our institution, a methodology that has been utilized in previous studies.^[@B28]^ The distance was classified as 0--10, 10--30, \>30--60, and \>60 miles. The primary interventions evaluated were surgical treatments, namely breast conservation, unilateral mastectomy, bilateral mastectomy (either for unilateral or bilateral breast cancer), and immediate postmastectomy breast reconstruction.

Statistical analyses {#s003}
--------------------

Descriptive statistics were performed. Clinical and demographic variables were examined by ethnicity using the chi-square test and Fisher\'s exact test when appropriate. The type of surgery and travel distance were examined by ethnicity using the chi-square test and Fisher\'s exact test when appropriate. Multivariable logistic regression models were developed to predict the odds of receiving a specific surgical operation, as a function of ethnicity. Variables found to be significant in univariate analysis (patient age, insurance status, and distance traveled) were included in multivariate analysis. We performed a subset analysis of patients who traveled \>30 miles so as to specifically query those patients seeking a tertiary care center distant from their home. For just those patients who traveled \>30 miles, type of surgery and travel distance were examined by ethnicity using the chi-square test and Fisher\'s exact test when appropriate. Multivariable logistic regression models were developed to predict the odds of receiving a specific surgical operation, as a function of ethnicity. Statistical analyses were conducted using Stata, v.5. *p*-Values \<0.05 were considered statistically significant.

Results {#s004}
=======

We identified a total of 1677 non-Hispanic patients (90.5%) and 175 Hispanic patients (9.4%) who received treatment for newly diagnosed DCIS or invasive breast cancer over a 5-year period. The distribution of tumor size and nodal stage did not differ between non-Hispanics and Hispanics (*p*=0.84 and *p*=0.22, respectively, [Table 1](#T1){ref-type="table"}). There were more Hispanic patients within the younger age groups (*p*\<0.001) and with Medicaid insurance (*p*\<0.001, [Table 1](#T1){ref-type="table"}).

###### 

**Clinical and Demographic Characteristics of Breast Cancer Patients by Ethnicity**

                     Non-Hispanic, *N* (%)   Hispanic, *N* (%)   *p*
  ------------------ ----------------------- ------------------- -------------
  Clinical T stage                                               
   Tis               280 (19.1)              23 (16.2)           0.841
   T1                639 (43.5)              64 (45.1)           
   T2                395 (26.9)              39 (27.5)           
   T3                121 (8.2)               11 (7.8)            
   T4                33 (2.3)                5 (3.5)             
  Clinical N stage                                               
   N0                1168 (77.7)             105 (79.7)          0.222
   N1                264 (18.0)              32 (22.4)           
   N2                22 (1.5)                5 (3.5)             
   N3                11 (0.8)                1 (0.7)             
  Age, years                                                     
   \<45              485 (22.1)              63 (34.6)           **\<0.001**
   45--54            671 (30.5)              56 (30.8)           
   55--64            474 (21.6)              36 (19.8)           
   65--74            378 (17.2)              19 (10.4)           
   75--84            119 (5.4)               7 (3.8)             
   85+               72 (3.3)                1 (0.6)             
  Insurance                                                      
   Private           1159 (54.1)             76 (41.7)           **\<0.001**
   Medicaid          213 (9.9)               56 (30.8)           
   Medicare          474 (22.1)              29 (15.9)           
   VA/Military       16 (8.42)               3 (1.6)             
   Uninsured         11 (0.5)                0 (0.0)             
   Unknown           270 (12.6)              18 (9.9)            

Bold indicates clinically significant values of *p* \< 0.05.

Notably, more than one-third (34.3%) of all patients traveled greater than 60 miles to receive surgical treatment. A significantly higher proportion of Hispanic women lived further from our cancer center than non-Hispanic women, with 37.9% of Hispanic women traveling greater than 60 miles to receive surgical care (*p*\<0.001, [Fig. 1](#f1){ref-type="fig"}). The largest difference between non-Hispanic and Hispanic patients was noted in the 30--60 mile range (9.8% vs. 18.3%, *p*\<0.001).

![Travel distance to the NCI-designated cancer center significantly differs by patient ethnicity; N Non-Hispanic=1765 and N Hispanic=173. NCI, National Cancer Institute; N, number of patients.](fig-1){#f1}

In terms of the type of surgery received, there were no significant differences among these two ethnic categories ([Fig. 2a](#f2){ref-type="fig"}). Specifically, rates of breast conservation were 57.4% and 52.3% (*p*=0.30), unilateral mastectomy 34.2% and 36.2% (*p*=0.44), and bilateral mastectomy 8.4% and 11.5% (*p*=0.24) for non-Hispanics and Hispanics, respectively. When evaluating immediate postmastectomy breast reconstruction, we found that 42.6% of non-Hispanics and 50.6% of Hispanics underwent reconstruction (*p*=0.34, [Fig. 2b](#f2){ref-type="fig"}).

![**(a)** No significant differences in receipt of breast cancer-directed surgery by ethnicity; N Non-Hispanic=1765 and N Hispanic=173. All comparisons by ethnicity were not statistically significant. **(b)** No significant differences in receipt of postmastectomy breast reconstruction by ethnicity; N Non-Hispanic=1765 and N Hispanic=173. All comparisons by ethnicity were not statistically significant.](fig-2){#f2}

In multivariate analysis ([Table 2](#T2){ref-type="table"}), Hispanic ethnicity was not associated with different odds of receiving breast conservation (odds ratio \[OR\] 1.01, confidence interval \[CI\] 0.73--1.40), unilateral mastectomy (OR 1.05, CI 0.75--1.44), bilateral mastectomy (OR 1.37, CI 0.81--2.31), or immediate postmastectomy breast reconstruction (OR 1.27, CI 0.86--1.88), when compared with non-Hispanic ethnicity, after controlling for patient age, insurance status, and distance traveled. However, Medicaid insurance was associated with lower odds of receiving postmastectomy reconstruction independent of race (OR 0.61, CI 0.42--0.90, *p*\<0.05). Increased age was associated with higher odds of receiving lumpectomy and lower odds of receiving unilateral mastectomy, bilateral mastectomy, and postmastectomy reconstruction ([Table 2](#T2){ref-type="table"}).

###### 

**Multivariate Analysis Evaluating the Odds of Receiving Breast Cancer Surgical Care**

                      Breast conservation, OR (95% CI)                       Unilateral mastectomy, OR (95% CI)                     Bilateral mastectomy, OR (95% CI)                        Postmastectomy reconstruction, OR (95% CI)
  ------------------- ------------------------------------------------------ ------------------------------------------------------ -------------------------------------------------------- ------------------------------------------------------
  Ethnicity                                                                                                                                                                                  
   Non-Hispanic       Ref                                                    Ref                                                    Ref                                                      Ref
   Hispanic           1.01 (0.73--1.40)                                      1.05 (0.75--1.44)                                      1.37 (0.81--2.31)                                        1.27 (0.86--1.88)
  Age, years                                                                                                                                                                                 
   \<45               Ref                                                    Ref                                                    Ref                                                      Ref
   45--54             1.96 (1.55--2.47)^[\*\*](#tf3){ref-type="table-fn"}^   0.53 (0.42--0.66)^[\*\*](#tf3){ref-type="table-fn"}^   *0.52 (0.37--0.74)^[\*\*](#tf3){ref-type="table-fn"}^*   0.66 (0.51--0.86)^[\*](#tf3){ref-type="table-fn"}^
   55--64             2.90 (2.23--3.76)^[\*\*](#tf3){ref-type="table-fn"}^   0.34 (0.26--0.44)^[\*\*](#tf3){ref-type="table-fn"}^   0.27 (0.17--0.43)*^[\*\*](#tf3){ref-type="table-fn"}^*   0.36 (0.27--0.51)^[\*\*](#tf3){ref-type="table-fn"}^
   65--74             2.68 (1.77--4.07)^[\*\*](#tf3){ref-type="table-fn"}^   0.37 (0.24--0.55)^[\*\*](#tf3){ref-type="table-fn"}^   0.10 (0.04--0.24)^[\*\*](#tf3){ref-type="table-fn"}^     0.15 (0.07--0.29)^[\*\*](#tf3){ref-type="table-fn"}^
   75--84             3.73 (2.13--6.55)^[\*\*](#tf3){ref-type="table-fn"}^   0.26 (0.15--0.45)^[\*](#tf3){ref-type="table-fn"}^     1.31 (0.86--1.98)                                        0.06 (0.02--0.20)^[\*\*](#tf3){ref-type="table-fn"}^
   \>85               2.29 (0.63--8.34)                                      0.27 (0.08--0.86)^[\*](#tf3){ref-type="table-fn"}^     n/a                                                      n/a
  Insurance                                                                                                                                                                                  
   Private            Ref                                                    Ref                                                    Ref                                                      Ref
   Medicaid           0.83 (0.63--1.12)                                      1.08 (0.82--1.43)                                      0.60 (0.34--1.05)                                        0.61 (0.42--0.90)^[\*](#tf3){ref-type="table-fn"}^
   Medicare           1.11 (0.75--1.64)                                      0.91 (0.61--1.33)                                      2.08 (0.97--4.46)                                        1.01 (0.55--1.85)
   VA/Military        0.96 (0.36--2.60)                                      0.90 (0.34--2.35)                                      n/a                                                      0.48 (0.11--2.14)
   Uninsured          2.30 (0.56--9.50)                                      0.40 (0.10--1.58)                                      n/a                                                      n/a
  Distance traveled                                                                                                                                                                          
   \<10 miles         Ref                                                    Ref                                                    Ref                                                      Ref
   10--29 miles       1.01 (0.79--1.28)                                      0.97 (0.77--1.24)                                      0.83 (0.55--1.26)                                        0.96 (0.71--1.34)
   30--59 miles       0.82 (0.58--1.15)                                      1.18 (0.85--1.64)                                      0.47 (0.23--0.94)^[\*](#tf3){ref-type="table-fn"}^       1.59 (1.06--2.39)
   \>60 miles         0.82 (0.64--1.05)                                      1.20 (0.94--1.54)                                      1.31 (0.86--1.98)                                        1.29 (0.94--1.79)

n/a notes that there were zero patients in this cell.

*p*\<0.01, ^\*\*^*p*\<0.001.

CI, confidence interval; OR, odds ratio.

When restricting the analysis to patients who traveled more than 30 miles, there were no significant differences in the rates of surgical care based on ethnicity ([Fig. 3a](#f3){ref-type="fig"}). In non-Hispanics and Hispanics, rates of breast conservation were 56.0% and 47.0% (*p*=0.30), unilateral mastectomy 34.8% and 42.0% (*p*=0.44), and bilateral mastectomy 9.2% and 11.0% (*p*=0.24), respectively. When evaluating immediate postmastectomy breast reconstruction, we found that 45.7% of non-Hispanics and 52.8% of Hispanics underwent reconstruction (*p*=0.34, [Fig. 3b](#f3){ref-type="fig"}).

![**(a)** No significant differences in receipt of breast cancer-directed surgery by ethnicity for patients who traveled \>30 miles; N Non-Hispanic=780 and N Hispanic=98. All comparisons by ethnicity were not statistically significant. **(b)** No significant differences in receipt of postmastectomy breast reconstruction by ethnicity for patients who traveled \>30 miles; N Non-Hispanic=780 and N Hispanic=98. All comparisons by ethnicity were not statistically significant.](fig-3){#f3}

Discussion {#s005}
==========

In this 5-year, retrospective single-institution study, breast cancer surgical care was found to be reassuringly similar among Hispanic patients compared with non-Hispanics. However, Hispanics on average traveled further to receive care at our institution compared with non-Hispanics and were more likely to be of young age and have Medicaid insurance.

Approximately 10% of our patient cohort was Hispanic compared with 12% of all patients cared for in the Stanford Cancer Institute and compared with 14% of new breast cancer patients in our catchment area. More than one-third of non-hispanic patients traveled greater than 60 miles to receive care at our cancer center, and this number was even higher for Hispanic patients. This is a surprising finding in light of other reports. For example, one study of multiple centers found that less than 2% of patients traveled \>100 km (∼60 miles) to receive surgical treatment of breast cancer.^[@B31]^ Using the National Cancer Database, Ward et al. described that 8% of all women with new nonmetastatic breast cancers were treated at a hospital \>50 miles from their home.^[@B32]^ Our results suggest that our center is unique in its ability to attract patients from a distance, especially with regard to Hispanic patients. Of note, our cancer center has initiated several efforts to reach Hispanic patients in the community and increase their participation in clinical care and clinical trials at our institution. These efforts include, but are not limited to, a cancer center webpage in Spanish, including videos interviewing Hispanic patients treated at our center, TV and radio advertisements in Spanish, hiring more medical staff who speak Spanish, providing accessible translation services, and hosting an annual educational event to encourage participation in clinical trials.

The type of breast cancer operation received among our Hispanic population did not differ significantly from non-Hispanics and thus is at odds with other published reports. Morris et al. found that Hispanic women in California with early stage breast cancer had lower odds of receiving breast-conserving surgery.^[@B33]^ Similarly Kurian et al., using the California Cancer Registry, found that Hispanic women were more likely to receive unilateral mastectomy than breast-conserving surgery and were less likely to undergo contralateral prophylactic mastectomy.^[@B8]^ Moreover, Alderman et al. reported that Hispanic women were less likely to receive immediate or delayed breast reconstruction.^[@B34]^ Despite Medicaid expansion, studies show that lower rates of immediate breast reconstruction persist among Hispanic patients.^[@B35]^

Our findings indicate that differences in surgical care based on ethnicity can wane in a dedicated tertiary comprehensive cancer center. This suggests that the hospital setting influences the level of services delivered. It is possible that our institution\'s efforts to increase Hispanic participation in clinical care at our hospital were successful and thus could be replicated in other Hispanic-serving hospitals. On the other hand, it is possible that Hispanic patients who traveled greater distances were perhaps more educated about healthcare delivery or simply had the means of traveling to an institution at a considerable distance. These findings differ from a report 20 years ago by Guidry et al. describing that white patients traveled further to receive breast cancer care than did black or Hispanic patients.^[@B25]^ In this series, Hispanic patients identified distance as a potential barrier to reach a hospital of choice.

We do not address whether Hispanic patients today experience fewer barriers to travel, but instead we focus on the elimination of differences in the quality of surgical care in a comprehensive cancer center setting. The vast majority of patients with breast cancer have the option to choose between lumpectomy or mastectomy as survival is equivalent for invasive cancers 4 cm or smaller.^[@B36]^ Neither rates of breast conservation nor tumor size varied by ethnicity at our institution. Hispanic patients who traveled further may have visited our center because of referral due to complexity of cases or lack of reconstructive services near their home, distrust of their local hospital, or as the result of publicity such as the Internet or TV advertisements that motivated them to travel outside a particular geographical area to access a perceived higher level of care.

One of the limitations of this single-institution experience is that the proportion of newly diagnosed breast cancer represented by Hispanic patients was only 9.4%, less than the 18.4% of all new breast cancers that occurred in Hispanic women recorded from 2009 to 2013 in California.^[@B37]^ Furthermore, the approximate incidence of breast cancers among Hispanic women in the top 3 most represented counties at our cancer center during the years of study was 2043,^[@B37]^ with only 173 seen at our center, and thus we can conclude that only a small proportion of Hispanic patients in our catchment area did arrive at our center for care and likely represent a unique population of patients.

While insurance plan designation may restrict access to private NCI-designated cancer centers, Hispanic patients treated at our hospital represented a higher percentage of Medicaid coverage than did non-Hispanics, suggesting that insurance status may not have been a limiting factor for those interested in receiving care at our center. Another limitation of our dataset is that it was unable to provide information about patient education level and household income, which are known to impact surgical breast cancer care.^[@B10]^ We also did not have a specific home address for the patients studied, and instead utilized the home zip code as a proxy, which is somewhat limited accuracy. Additionally, our analysis did not evaluate the unknowns of car ownership, utilization of rail access or public transit, familial support for travel, or the practice of seeking second opinions, which all influence travel distance to a hospital.

Conclusions {#s006}
===========

Non-Hispanic and Hispanic patients had similar receipt of breast conservation, unilateral mastectomy, bilateral mastectomy, and immediate postmastectomy breast reconstruction at our academic NCI cancer center despite a large body of literature demonstrating ethnic differences in these domains of treatment. Uniquely, Hispanic patients traveled further than other patients to receive care at our hospital, in contradiction to prior reports of minority patients traveling shorter distances for cancer care on average. The capacity of some Hispanic patients to travel to a hospital of choice is likely related to complex cultural and socioeconomic factors and would benefit from further investigation.
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